| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,084 |
6,093 |
$523K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,179 |
2,171 |
$158K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,181 |
1,052 |
$96K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,670 |
2,474 |
$70K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
343 |
335 |
$34K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,183 |
1,164 |
$28K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,050 |
1,944 |
$26K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,565 |
1,312 |
$16K |
| 71046 |
Radiologic examination, chest; 2 views |
395 |
376 |
$7K |
| 36415 |
Collection of venous blood by venipuncture |
1,042 |
964 |
$4K |
| 81002 |
|
496 |
474 |
$1K |
| 81025 |
|
192 |
188 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
470 |
440 |
$831.32 |
| 87807 |
|
83 |
80 |
$520.80 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
259 |
219 |
$483.01 |
| 87276 |
|
39 |
38 |
$305.90 |
| 87275 |
|
39 |
38 |
$233.45 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
636 |
583 |
$182.10 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
100 |
80 |
$143.78 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
14 |
14 |
$74.35 |
| 99051 |
|
36 |
35 |
$0.00 |